JPRN-UMIN000040753招募中未知
Observational study to reveal the risk of HTLV-1 infection in organ transplantation using HTLV-1 organ transplantation registry - HTLV-1 organ transplantation registry
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients considered unsuitable for participation in the study by the investigator.
研究者
相似试验
Unknown
2 期
Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)HTLV-I-Associated MyelopathyNCT01343355St. Marianna University School of Medicine15
已完成
3 期
ung Cancer Evaluation of TS-1 StudyPreviously untreated stageIIIB/IV NSCLCJPRN-UMIN000000503West Japan Oncology Group560
终止
1 期
This study is examining the safety and tolerability of a new drug (Everolimus) in combination with chemotherapy in the treatment of relapsed adult acute lymphobastic leukaemiaacute lymphobastic leukaemia (ALL)Cancer - Leukaemia - Acute leukaemiaACTRN12610000405011Australasian Leukaemia and Lymphoma Group20
已完成
1 期
Safety and tolerability studies of Quercetin bar in healthy subjectsCTRI/2021/07/035309Director Defence Institute of Physiology and Allied Sciences20
终止
1 期
A first-in-human study of VG161 in participants with advanced malignant tumours that have not responded to conventional therapies.Advanced malignant solid tumorsCancer - Other cancer typesCancer - Any cancerACTRN12620000244909Virogin Biotech Australia Pty. Ltd.7